Scroll to explore more. Hot Topics including JAK differentiation, efficacy, PROs, safety and other practicalities.


Prof. Choy explains the mechanism of action of JAK Inhibitors


Prof. Mysler explains how to use baricitinib for treatment in patients with RA and discusses the strong evidence for baricitinib based on Phase 3 RA-BEAM study.


Dr. Grisar explains the importance of using PROs and clinical disease activity measures in patient-centered care and discuses the effect of baricitinib on PROs.


Prof. Durez and Prof. Feist consider the different aspects of baricitinib's safety profile in RA that has been characterised by an extensive safety analysis.

Watch Video Button Blue-800


Dr. Sewerin and other leading rheumatology experts address your practical concerns regarding the use of baricitinib in patients.

Hot Topics 5

This is a restricted page.